The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Neptune Technologies & Bioressources Inc

Nasdaq: NEPT
Last

(U.S.) $1.04

Today's change+0.05 +4.84%
Updated December 6 4:00 PM -5GMT. Delayed by at least 15 minutes.
 

Neptune Technologies & Bioressources Inc

Nasdaq: NEPT
Last

(U.S.) $1.04

Today's change+0.05 +4.84%
Updated December 6 4:00 PM -5GMT. Delayed by at least 15 minutes.

Neptune Technologies & Bioressources Inc crosses above 20-day moving average

Neptune Technologies & Bioressources Inc closed up sharply Tuesday, rallying (U.S.)$0.05 or 4.84% to (U.S.)$1.04 and crossing above its 20-day moving average. Over the last five days, shares have gained 2.97%, but are currently unchanged over the last year to date. Shares have underperformed the S&P 500 by 15.33% during the last year.

Key company metrics

  • Open(U.S.) $1.00
  • Previous close(U.S.) $0.99
  • High(U.S.) $1.12
  • Low(U.S.) $1.00
  • Bid / Ask(U.S.) $1.04 / (U.S.) $1.05
  • YTD % change-2.80%
  • Volume1,184,329
  • Average volume (10-day)267,765
  • Average volume (1-month)406,396
  • Average volume (3-month)284,353
  • 52-week range(U.S.) $0.86 to (U.S.) $1.53
  • Beta0.12
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward33.07×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.06
Updated December 6 4:00 PM -5GMT. Delayed by at least 15 minutes.

Latest Company News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedAug 31, 201608/31/2016May 31, 201605/31/2016Feb 29, 201602/29/2016Nov 30, 201511/30/2015
Revenue1211106
Total other revenue--------
Total revenue1211106
Gross profit3432
Total cost of revenue9874
Total operating expense1414129
Selling / general / administrative34123
Research & development1212
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total0---8-1
Operating income-2-2-2-3
Interest income (expense), net non-operating-1-100
Gain (loss) on sale of assets--------
Other--------
Income before tax-2-4-2-3
Income after tax-2-40-3
Income tax, total00-20
Net income-1-21-2
Total adjustments to net income--------
Net income before extra. items-1-21-2
Minority interest1211
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1-21-2
Inc. avail. to common incl. extra. items-1-21-2
Diluted net income-1-21-2
Dilution adjustment--------
Diluted weighted average shares78787775
Diluted EPS excluding extraordinary itemsvalue per share-0.02-0.030.01-0.02
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.02-0.030.01-0.02